Live Vaccines has 25 known drug interactions based on U.S. FDA drug labeling data. Of these, 16 are contraindicated combinations that should be avoided entirely. 2 are classified as major interactions requiring close medical supervision. Notable interactions include combinations with Adalimumab, Adalimumab-Aacf, Adalimumab-Aaty. Patients taking Live Vaccines should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 25
- Contraindicated
- 16
- Major
- 2
- Moderate
- 5
Contraindicated (16)
- Live Vaccines + Adalimumab— Avoid use with HUMIRA due to immunosuppression.
- Live Vaccines + Adalimumab-Aacf— Avoid use of live vaccines with ADALIMUMAB-AACF.
- Live Vaccines + Adalimumab-Aaty— Avoid use with YUFLYMA due to risk of vaccine-strain disease in immunocompromised patients.
- Live Vaccines + Adalimumab-Adaz— Avoid use of live vaccines with adalimumab-adaz.
- Live Vaccines + Adalimumab-Adbm— Avoid use of live vaccines with adalimumab-adbm due to risk of infection in immunocompromised patients.
- Live Vaccines + Adalimumab-Afzb— Avoid use of live vaccines with ABRILADA due to risk of infection in immunocompromised patients.
- Live Vaccines + Adalimumab-Aqvh— Avoid use of live vaccines with YUSIMRY.
- Live Vaccines + Adalimumab-Atto— Avoid use of live vaccines with AMJEVITA due to immunosuppression risk.
- Live Vaccines + Adalimumab-Bwwd— Avoid use of live vaccines with HADLIMA.
- Live Vaccines + Adalimumab-Fkjp— Avoid use of live vaccines with adalimumab-fkjp due to immunosuppression risk.
- Live Vaccines + Adalimumab-Ryvk— Avoid use of live vaccines with adalimumab-ryvk.
- Live Vaccines + Etanercept— Concurrent administration should be avoided due to risk of vaccine-strain infection in immunocompromised patients.
- Live Vaccines + Golimumab— Live vaccines should not be given concurrently with golimumab. Avoid use.
- Live Vaccines + Sarilumab— Avoid concurrent use of live vaccines during treatment with KEVZARA.
- Live Vaccines + Tocilizumab— Avoid use of live vaccines concurrently with tocilizumab.
- Live Vaccines + Tocilizumab-Aazg— Avoid concurrent use of live vaccines with tocilizumab.
Major (2)
- Live Vaccines + Canakinumab— Avoid concurrent administration with live vaccines due to unknown effects on vaccine efficacy and risk of secondary tran…
- Live Vaccines + Infliximab-Dyyb— Live vaccines not recommended concurrently with infliximab. Live vaccines also not recommended for infants with in utero…
Moderate (5)
- Live Vaccines + Ansuvimab— EBANGA may reduce the efficacy of live vaccine for Orthoebolavirus zairense. Avoid concurrent administration during trea…
- Live Vaccines + Atoltivimab, Maftivimab, And Odesivimab-Ebgn— INMAZEB may reduce the efficacy of the live vaccine. Avoid concurrent administration during treatment; interval between …
- Live Vaccines + Certolizumab Pegol— Avoid use of live or attenuated vaccines during or immediately prior to initiation of CIMZIA therapy.
- Live Vaccines + Marnetegragene Autotemcel— Vaccination not recommended during the 6 weeks preceding myeloablative conditioning start and until hematological recove…
- Live Vaccines + Mefloquine Hydrochloride— Attenuation of immunization cannot be excluded when mefloquine taken concurrently. Complete vaccinations with attenuated…